Skip to main content
AAN.com

Abstract

Objectives:

The impact of chronic kidney disease (CKD) on clinical outcomes after acute ischemic stroke is still not fully understood. The aim of the present study was to elucidate how CKD and its components, proteinuria and low estimated glomerular filtration rate (eGFR), affect the clinical outcomes after ischemic stroke.

Methods:

The study subjects consisted of 3,778 patients with first-ever ischemic stroke within 24 hours of onset from the Fukuoka Stroke Registry. CKD was defined as proteinuria or low eGFR (<60 mL/min/m2) or both. The study outcomes were neurologic deterioration (≥2-point increase in the NIH Stroke Scale during hospitalization), in-hospital mortality, and poor functional outcome (modified Rankin Scale score at discharge of 2 to 6). The effects of CKD, proteinuria, and eGFR on these outcomes were evaluated using a multiple logistic regression analysis.

Results:

CKD was diagnosed in 1,320 patients (34.9%). In the multivariate analyses after adjusting for confounding factors, patients with CKD had significantly higher risks of neurologic deterioration, in-hospital mortality, and poor functional outcome (p <0.001 for all). Among the CKD components, a higher urinary protein level was associated with an elevated risk of each outcome (p for trend < 0.001 for all), but no clear relationship between the eGFR level and each outcome was found.

Conclusions:

CKD is an important predictor of poor clinical outcomes after acute ischemic stroke. Proteinuria independently contributes to the increased risks of neurologic deterioration, mortality, and poor functional outcome, but the eGFR may not be relevant to these outcomes.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (kumai.pdf)
File (table_e-1.doc)
File (table_e-2.doc)
File (znl02412001898.pdf)

REFERENCES

1.
Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study. J Am Soc Nephrol 2003; 14: S131– 138.
2.
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1– 12.
3.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296– 1305.
4.
Nickolas TL, Khatri M, Boden-Albala B, et al. The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the Northern Manhattan Study (NOMAS). Stroke 2008; 39: 2876– 2879.
5.
Ninomiya T, Kiyohara Y, Tokuda Y, et al. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008; 118: 2694– 2701.
6.
Ovbiagele B. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke. Arch Neurol 2008; 65: 934– 938.
7.
McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000; 36: 679– 684.
8.
Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285– 1295.
9.
Brosius FC, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 2006; 114: 1083– 1087.
10.
MacWalter RS, Wong SY, Wong KY, et al. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. Stroke 2002; 33: 1630– 1635.
11.
Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant 2009; 24: 194– 200.
12.
Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009; 40: 1296– 1303.
13.
Agrawal V, Rai B, Fellows J, McCullough PA. In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. Nephrol Dial Transplant 2010; 25: 1150– 1157.
14.
Naganuma M, Koga M, Shiokawa Y, et al. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011; 31: 123– 129.
15.
Kamouchi M, Matsuki T, Hata J, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke 2011; 42: 2788– 2794.
16.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539– 553.
17.
Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423– 429.
18.
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982– 992.
19.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1– 266.
20.
Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119: 1363– 1369.
21.
Toyoda K, Fujimoto S, Kamouchi M, Iida M, Okada Y. Acute blood pressure levels and neurological deterioration in different subtypes of ischemic stroke. Stroke 2009; 40: 2585– 2588.
22.
Brzosko S, Szkolka T, Mysliwiec M. Kidney disease is a negative predictor of 30-day survival after acute ischaemic stroke. Nephron Clin Pract 2009; 112: c79– 85.
23.
Ovbiagele B, Sanossian N, Liebeskind DS, et al. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease. Cerebrovasc Dis 2009; 28: 582– 588.
24.
Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006; 69: 1264– 1271.
25.
Madison JR, Spies C, Schatz IJ, et al. Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: the Honolulu Heart Program. Arch Intern Med 2006; 166: 884– 889.
26.
Agrawal V, Marinescu V, Agarwal M, McCullough PA. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol 2009; 6: 301– 311.
27.
Rodriguez-Yanez M, Castellanos M, Blanco M, et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 2006; 67: 1172– 1177.
28.
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038– 2047.
29.
Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005; 45: 1058– 1066.

Information & Authors

Information

Published In

Neurology®
Volume 78Number 24June 12, 2012
Pages: 1909-1915
PubMed: 22592359

Publication History

Received: June 25, 2011
Accepted: October 17, 2011
Published online: May 16, 2012
Published in print: June 12, 2012

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.

Authors

Affiliations & Disclosures

Y. Kumai, MD*
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
M. Kamouchi, MD*
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
J. Hata, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
T. Ago, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
J. Kitayama, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
H. Nakane, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
H. Sugimori, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
T. Kitazono, MD
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.
For the FSR Investigators
From the Cerebrovascular and Neurology Center (Y.K., J.K., H.N.), National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka; Departments of Medicine and Clinical Science (Y.K., M.K., J.H., T.A., J.K., H.N., H.S., T.K.) and Environmental Medicine (J.H.), Graduate School of Medical Sciences, Kyushu University; and Department of Nephrology, Hypertension and Strokology (M.K., T.A., T.K.) and Emergency and Critical Care Center (H.S.), Kyushu University Hospital, Kyushu, Japan.

Notes

*
These authors contributed equally to this work.
Study funding: Supported by a Grant-in-Aid for Scientific Research (A 22249069) and Coordination, Support and Training Program for Translational Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Correspondence & reprint requests to Dr. Kamouchi: [email protected]

Author Contributions

Y. Kumai contributed to drafting the manuscript for content, study concept, analysis of data, and acquisition of data. M. Kamouchi contributed to drafting the manuscript for content, study concept, analysis of data, acquisition of data, and statistical analysis. J. Hata contributed to the study concept and statistical analysis. T. Ago contributed to the study concept, analysis of data, and acquisition of data. J. Kitayama contributed to the analysis of data and acquisition of data. H. Nakane contributed to the study concept, acquisition of data, and study supervision. H. Sugimori contributed to the study concept, analysis of data, and study supervision. T. Kitazono contributed to the study concept, study supervision, and obtaining funding.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Chronic Kidney Disease and Cerebrovascular Pathology: Incidence and Functional Outcomes in Riga East University Hospital, Medicina, 60, 2, (219), (2024).https://doi.org/10.3390/medicina60020219
    Crossref
  2. The Factors Influencing Chronic Kidney Disease Incidence: Database from the Korean National Health Insurance Sharing Service (NHISS), Journal of Clinical Medicine, 13, 8, (2164), (2024).https://doi.org/10.3390/jcm13082164
    Crossref
  3. Serum uric acid as a predictor of mortality in patients with stroke: results from National Health and Nutrition Examination Survey 2007–2016, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1383300
    Crossref
  4. Prevalence of Cognitive Impairment in Dialysis Patients in Gauteng Province, South Africa, Journal of Clinical Nephrology, 8, 2, (103-113), (2024).https://doi.org/10.29328/journal.jcn.1001136
    Crossref
  5. Predictive Performance of Machine Learning–Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study, JMIR AI, 3, (e46840), (2024).https://doi.org/10.2196/46840
    Crossref
  6. Cerebrovascular carbon dioxide reactivity is intact in chronic kidney disease, Physiological Reports, 12, 7, (2024).https://doi.org/10.14814/phy2.15998
    Crossref
  7. Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke, PLOS ONE, 19, 1, (e0296833), (2024).https://doi.org/10.1371/journal.pone.0296833
    Crossref
  8. Body temperature in the acute phase and clinical outcomes after acute ischemic stroke, PLOS ONE, 19, 1, (e0296639), (2024).https://doi.org/10.1371/journal.pone.0296639
    Crossref
  9. Inflammation and Adverse Outcomes in Patients With Acute Ischemic Stroke With and Without Chronic Kidney Disease, Journal of the American Heart Association, 13, 9, (2024).https://doi.org/10.1161/JAHA.123.033450
    Crossref
  10. Radiologic and Blood Markers Predicting Long-Term Neurologic Outcome Following Decompressive Craniectomy for Malignant Ischemic Stroke: A Preliminary Single-Center Study, Journal of Neurological Surgery Part A: Central European Neurosurgery, (2024).https://doi.org/10.1055/a-2312-9448
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share